Skip to main content
Theo Heller, MD, Gastroenterology, Bethesda, MD

Theo Heller MD

Gastroenterology•Bethesda, MD

Hepatology & Liver Transplantation

Chief, Translational Hepatology Section, NIDDK, NIH.

Join to view full profile

  • 8600 Old Georgetown RdBethesda, MD 20814

  • Phone+1 301-896-3517

  • Fax+1 301-493-4259

Dr. Heller is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Heller's full profileAlready have an account?

Summary

  • Theo Heller, MD, is a gastroenterologist based in Bethesda, MD, with subspecialties in hepatology and liver transplantation. His education includes a fellowship in gastroenterology at the University of Maryland and a residency in internal medicine at MedStar Health/Georgetown University Hospital. Dr. Heller has experience in hepatology and colorectal cancer, and he has contributed to several publications, including studies on gastrectomies, liver enzyme levels, and splenic elastography. His involvement in clinical trials includes work on treatment approaches for chronic hepatitis D and the immune response to hepatitis C virus.

Education & Training

  • University of Maryland
    University of MarylandFellowship, Gastroenterology, 1997 - 2000
  • MedStar Health Georgetown University/Georgetown Hospital
    MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1990 - 1993
  • University of the Witwatersrand
    University of the WitwatersrandClass of 1989

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1992 - 2026

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Characterization of the Hepatosplenic and Portal Venous Findings in Patients with Proteus Syndrome  
    Theo Heller, MD, American Journal of Medical Genetics. Part A
  • Rheological Determinants for Simultaneous Staging of Hepatic Fibrosis and Inflammation in Patients with Chronic Liver Disease  
    Ahmed M Gharib, Theo Heller, NMR in Biomedicine

Press Mentions

  • FDA Rejects Full Approval of Liver Disease Drug
    FDA Rejects Full Approval of Liver Disease DrugNovember 12th, 2024
  • Approved Liver Disease Drug Has No Clinical Benefit, FDA Panel Says
    Approved Liver Disease Drug Has No Clinical Benefit, FDA Panel SaysSeptember 13th, 2024
  • FDA Summit on Gene Therapy Risks Proves Timely
    FDA Summit on Gene Therapy Risks Proves TimelySeptember 7th, 2021

Grant Support

  • Investigation of management and disease manifestations of viral hepatitisNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent
  • Investigation of management and disease manifestations of viral hepatitisNATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent
  • Investigation of non-cirrhotic portal hypertension.NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESPresent

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Theo Heller, Dr. Theo Heller, MD, Dr. T Heller